AU2002211538A1 - Compounds for sustained release of orally delivered drugs - Google Patents

Compounds for sustained release of orally delivered drugs

Info

Publication number
AU2002211538A1
AU2002211538A1 AU2002211538A AU1153802A AU2002211538A1 AU 2002211538 A1 AU2002211538 A1 AU 2002211538A1 AU 2002211538 A AU2002211538 A AU 2002211538A AU 1153802 A AU1153802 A AU 1153802A AU 2002211538 A1 AU2002211538 A1 AU 2002211538A1
Authority
AU
Australia
Prior art keywords
compounds
sustained release
orally delivered
delivered drugs
drugs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002211538A
Other languages
English (en)
Inventor
Kenneth C. Cundy
Mark A. Gallop
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
XenoPort Inc
Original Assignee
XenoPort Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by XenoPort Inc filed Critical XenoPort Inc
Priority claimed from PCT/US2001/031486 external-priority patent/WO2002028411A1/en
Publication of AU2002211538A1 publication Critical patent/AU2002211538A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU2002211538A 2000-10-06 2001-10-05 Compounds for sustained release of orally delivered drugs Abandoned AU2002211538A1 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US23875800P 2000-10-06 2000-10-06
US60238758 2000-10-06
US24980400P 2000-11-17 2000-11-17
US60249804 2000-11-17
US29764101P 2001-06-11 2001-06-11
US29759401P 2001-06-11 2001-06-11
US29765401P 2001-06-11 2001-06-11
US60297641 2001-06-11
US60297594 2001-06-11
US60297654 2001-06-11
PCT/US2001/031486 WO2002028411A1 (en) 2000-10-06 2001-10-05 Compounds for sustained release of orally delivered drugs

Publications (1)

Publication Number Publication Date
AU2002211538A1 true AU2002211538A1 (en) 2002-04-15

Family

ID=27540106

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002211538A Abandoned AU2002211538A1 (en) 2000-10-06 2001-10-05 Compounds for sustained release of orally delivered drugs

Country Status (2)

Country Link
EP (1) EP1343515A4 (de)
AU (1) AU2002211538A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355009A (en) * 1999-07-30 2001-04-11 Univ Glasgow Peptides conjugated to bile acids/salts
EP2085087A1 (de) * 2001-06-11 2009-08-05 Xenoport, Inc. Prodrugs aus GABA-Analoga, Zusammensetzungen und ihre Verwendungen

Also Published As

Publication number Publication date
EP1343515A1 (de) 2003-09-17
EP1343515A4 (de) 2005-08-03

Similar Documents

Publication Publication Date Title
AU2002258563A1 (en) Pharmaceutical formulations for sustained release
HUP0301921A3 (en) Sustained release pharmaceutical compositions for paranteral administration of hydrophilic compounds
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU6089200A (en) Rapid immediate release oral dosage form
AU2002229140A1 (en) Controlled release pharmaceutical composition
AU2001248769A1 (en) Time-release coated solid compositions for oral administration
AU2276801A (en) Extended release oral dosage composition
AU2002248377A1 (en) A controlled release pharmaceutical composition
AU2002363360A1 (en) Dual controlled release dosage form
AU2002337803A1 (en) Sustained release pharmaceutical compositions
AUPR602501A0 (en) Sustained release pharmaceutical composition
AU2001287977A1 (en) Controlled release formulations for oral administration
AU2002360717A1 (en) Controlled release dosage form having improved drug release properties
HUP0301177A3 (en) Ion-strength independent sustained release pharmaceutical formulation
AU2002228119A1 (en) Thermoformable solid pharmaceutical composition for controlled release of ivabradine
AU2001232948A1 (en) Controlled release of drugs
AU2001252296A1 (en) A peroral pharmaceutical formulation for controlled release of a drug
AU2001227030A1 (en) Pharmaceutical composition for controlled release of an active ingredient
AU2001248772A1 (en) Sustained release drug compositions
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
AUPR951501A0 (en) Modified sustained release pharmaceutical system
AU2001221695A1 (en) Solid pharmaceutical compositions for controlled release of active substances
AU2003260239A1 (en) Solid dosage forms for rapid dissolution of poorly soluble drugs
AU2001267782A1 (en) Fast release bioadhesive microspheres for the sublingual administration of proximate principles
AU2001292301A1 (en) Novel drugs for liver diseases